This week on IPWatchdog Unleashed, we enter the patent litigation world for a conversation about gaming patent litigation. For too long, popular sentiment has been that patent owners are bad actors ...
A Texas federal judge ordered an embattled attorney to seek the court’s permission before filing any further patent suits in one of the nation’s busiest patent venues.
Texas remains home to two of the federal district courts with the largest patent-lawsuit workloads, and jurors in the Lone ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts. Pfizer and ...
The Association for Accessible Medicines and the Biosimilars Council released a white paper, Serial Patent Litigation Problems and Solutions, which AAM said analyzes the increasingly common practices ...
Armond Wilson partners Monica Arnold and Michelle Armond are back with the latest installment of their year-end column ...
Esperion settles patent litigation with Micro Labs, extending protection for NEXLETOL until April 2040, with ongoing litigation against other defendants. Esperion has reached a settlement with Micro ...
Esperion announced a settlement with Accord Healthcare that resolves patent litigation over Accord's attempt to market a generic version of NEXLETOL before patent expiration. The agreement prevents ...
BeOne Medicines and AbbVie’s Pharmacyclics have decided to voluntarily dismiss the patent lawsuit the Big Pharma firm brought against its competitor over their BTK inhibitors. The patent covers a ...
Moderna, Inc.'s stock surged 16% yesterday after a German court ruled Pfizer and BioNTech may have violated Moderna's COVID-19 vaccine patent, potentially leading to compensation. Despite the ruling, ...
Expect to see a more mature system of IP litigation in China in the years to come. The predicted increase in the number of IP court cases will provide invaluable experience for trial lawyers, argues ...